Neurovance is Drug Discovery in United States that focus on triple re business. Founded in 2011. They cover business area such as developer, lack, focus, inattention, disorganization, adhd patient, -uptake inhibitor, Centanafadine, (CTN, norepinephrine, a specific result, attention-deficit hyperactivity disorder.
2011
( 13 years old in 2024 )
Triple Re
-
43 Thorndike Street
Suite S1-3
Cambridge, MA 02141
United States
Private
developerlackfocusinattentiondisorganizationadhd patient-uptake inhibitorCentanafadine(CTNnorepinephrinea specific resultattention-deficit hyperactivity disorder
* We use standard office opening hours in near Neurovance's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Neurovance is Drug Discovery business from United States that founded in 2011 (13 years old in 2024), Neurovance business is focusing on Triple Re.
Neurovance headquarter office and corporate office address is located in 43 Thorndike Street Suite S1-3 Cambridge, MA 02141 United States.
Neurovance was founded in United States.
In 2024, Neurovance is currently focus on triple re sector.
Above is snippet of Google Trends for "triple re" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Neurovance, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
